v3.25.4
Segment and other information (Tables)
12 Months Ended
Dec. 31, 2025
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information
The following table provides segment revenues, significant segment expenses, other segment items and reported segment net income for the Company’s one reportable segment, as well as a reconciliation of segment net income to the Company’s total consolidated net income for the years ended December 31, 2025, 2024 and 2023 (in millions):
Years ended December 31,
202520242023
Revenues:
Product sales$35,148 $32,026 $26,910 
Other revenues1,603 1,398 1,280 
Total revenues36,751 33,424 28,190 
Less:
Manufacturing cost of sales(1)(2)
9,845 11,118 7,347 
Profit share and royalties in cost of sales(1)
2,192 1,740 1,104 
Research and development(1)
7,272 5,964 4,784 
Sales and marketing(1)
4,590 4,713 3,784 
General and administrative(1)
2,460 2,383 2,395 
Other segment items(3)
(931)252 (729)
Interest income
(408)(510)(1,225)
Interest expense, net2,755 3,155 2,875 
Provision for income taxes
1,265 519 1,138 
Segment net income7,711 4,090 6,717 
Reconciliation of profit or loss:
Adjustments and reconciling items— — — 
Consolidated net income$7,711 $4,090 $6,717 
____________
(1)    During the years ended December 31, 2025, 2024 and 2023, we recognized amortization expense on our intangible assets of $4.3 billion, $4.8 billion and $3.2 billion, respectively. Amortization of intangible assets is primarily included in Cost of sales in the Consolidated Statements of Income. In addition, during the years ended December 31, 2025, 2024 and 2023, we recognized depreciation and ROU asset amortization expense of $887 million, $805 million and $824 million, respectively.
(2)    During the years ended December 31, 2025, 2024 and 2023, manufacturing cost of sales included amortization of step-up to fair value of inventory acquired in business combinations of $1.3 billion, $2.4 billion and $656 million, respectively.
(3)    Other segment items included in Segment net income primarily consists of: (i) fair value adjustments on equity securities (see Note 10, Investments); (ii) net impairment charges on intangible assets (see Note 13, Goodwill and other intangible assets); and (iii) expenses related to restructuring and cost-savings initiatives.